Novartis AG (NYSE:NVS)

During the Trading Day
84.59 -1.58 / -1.83%
Data as of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
84.61 +0.02 / +0.02%
 
Volume: 93.0K
Why Investors Should Love Biogen's Earnings Miss
6:30pm / MotleyFool.com
Why Novartis (NVS) Stock Is Up Today
Apr 22 / TheStreet.com
Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns
5:46pm / Benzinga
Novartis Reshapes Portfolio via GSK, Eli Lilly Deals
Apr 22 / TheStreet.com
Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog
2:37pm / Zacks.com
Notable Mergers and Acquisitions of the Day 04/22: (GSK)/(NVS) (VRX)/(AGN) (CDNS)
Apr 22 / Investing Channel
Healthcare M&A activity hits record level
12:43pm / Fortune
5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits
Apr 22 / TheStreet.com
Botox at the Center of Recent Healthcare M&A Flurry
11:13am / TheStreet.com
Novartis (NVS) Reaches New Lifetime High Today
Apr 22 / TheStreet.com
Earnings Roundup: Biogen's Tecfidera Wins More Share
9:31am / MotleyFool.com
Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis ...
Apr 22 / MotleyFool.com
Today's Top Health Care Stocks to Watch: AstraZeneca plc, Alexion Pharmaceuticals, Ce...
8:40am / MotleyFool.com
US Stock Futures Edge Higher Ahead Of McDonald's Earnings
Apr 22 / Benzinga
UPDATE: Novartis Posts Rise In Q1 Profit
6:58am / Benzinga
Botox maker gets $46 billion bid
Apr 22 / CNNMoney.com
Earnings Scheduled For April 24, 2014
6:58am / Benzinga
Why GlaxoSmithKline (GSK) Stock Is Higher This Morning
Apr 22 / TheStreet.com
Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog
Apr 23 / Zacks.com
Stocks: Pharma, earnings in the spotlight
Apr 22 / CNNMoney.com
Novartis Signs Deals with Glaxo, Lilly - Analyst Blog
Apr 23 / Zacks.com
Why Teva (TEVA) Stock Is Lower
Apr 21 / TheStreet.com
Stock Market News for April 23, 2014 - Market News
Apr 23 / Zacks.com
Roche Meets Sales Estimates in Q1 - Analyst Blog
Apr 17 / Zacks.com
Benzinga's M&A Chatter for Tuesday April 22, 2014
Apr 22 / Benzinga
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Apr 17 / MotleyFool.com
Eli Lilly to Acquire Novartis' Animal Health Biz - Analyst Blog
Apr 22 / Zacks.com
Foreign Stocks: Balance Your Portfolio and Profit From Global Growth
Apr 16 / MotleyFool.com
Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positiv...
Apr 22 / Benzinga
Does Pfizer Offer Good Value?
Apr 15 / MotleyFool.com
Why GW Pharmaceuticals, Revance Therapeutics, and Allergan Are Today's 3 Best Stocks
Apr 22 / MotleyFool.com
Update on BioLineRx's BL-8040 - Analyst Blog
Apr 11 / Zacks.com
5 reasons to care about Ackman's Botox bet
Apr 22 / CNNMoney.com
Balanced Risk-Reward for The Cooper Companies - Analyst Blog
Apr 11 / Zacks.com
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Apr 22 / Benzinga
Can This Drug Be a Game Changer for Eli Lilly?
Apr 11 / MotleyFool.com
Is This a Good Deal for Novartis AG and GlaxoSmithKline plc?
Apr 22 / MotleyFool.com
3 Breast Cancer Drugs With Big Potential
Apr 10 / MotleyFool.com
Tuesday Links: Bullish On Hedge Funds
Apr 22 / StockTwits
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.